GeorgeEarlPeoplesJr.MD
General Surgery • Fort Sam Houston, TXSurgical Oncology (Other than Breast)
Physician
Are you Dr. Peoples?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 101 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
3851 Roger Brooke Dr
Fort Sam Houston, TX 78234Phone+1 210-916-4235Fax+1 210-916-5102
Summary
- Dr. George Peoples Jr., MD is a general surgeon in Fort Sam Houston, Texas. He is currently licensed to practice medicine in Texas.
Education & Training
Brigham and Women's HospitalResidency, Surgery, 1989 - 1996
National Capital ConsortiumInternship, Transitional Year, 1988 - 1989
Johns Hopkins University School of MedicineClass of 1988
Certifications & Licensure
TX State Medical License 1996 - 2025
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Vaccine Therapy in Treating Patients With Breast Cancer Start of enrollment: 2007 Jan 01
- Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Node-Positive Breast Cancer Patients Start of enrollment: 2001 Jul 01
- Safety and Efficacy Study of HER2/Neu (E75) Vaccine in Breast Cancer Start of enrollment: 2002 Dec 01
Publications & Presentations
PubMed
- Results of a phase I/IIa trial of SV-BR-1-GM inoculation with low-dose cyclophosphamide and interferon alpha (Bria-IMT) in metastatic breast cancer.Charles L Wiseman, Jarrod P Holmes, Carmen Calfa, Shaker R Dakhil, Saveri Bhattacharya
Human Vaccines & Immunotherapeutics. 2024-12-31 - The benefit of adjuvant chemotherapy following pancreaticoduodenectomy for pancreatic adenocarcinoma depends on response to neoadjuvant therapy.Elizabeth L Carpenter, Spencer G Van Decar, Patrick M McCarthy, Franklin A Valdera, Alexandra M Adams
Journal of Surgical Oncology. 2024-07-01 - 1 citationsEstrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast Cancer.Jonathan Goldberg, Na Qiao, Jennifer L Guerriero, Brett Gross, Yagiz Meneksedag
Cancer Research Communications. 2024-02-22
Press Mentions
Emtora Clinical Data to be Highlighted in Podium Presentation at Prestigious 2024 Digestive Disease Week Annual MeetingMay 6th, 2024
Calidi Biotherapeutics Announces Appointment of Dr. George Peoples, a Prominent Immuno-Oncology Expert, to Its Scientific and Medical Advisory BoardFebruary 27th, 2020
Texas-Based Cancer Insight Helps Clients ObtainAugust 28th, 2019- Join now to see all
Professional Memberships
- Member
